rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
21
|
pubmed:dateCreated |
1988-12-9
|
pubmed:abstractText |
Recombinant human interferon-beta 2 was produced in Escherichia coli by direct expression of cDNA encoding the mature protein sequence. At concentrations that stimulate DNA synthesis and growth in B-cell hybridomas and plasmacytomas, the cytokine was found to exert a strong inhibition on the growth of a number of carcinoma and leukemia/lymphoma cell lines. This antigrowth effect was observed in clonogenic assays and by measurements of cell number and thymidine incorporation in growing cultures. The effect was blocked by antibodies to a synthetic peptide from the N terminus of the molecule. Normal diploid fibroblasts were inhibited at concentrations higher than those needed for breast carcinoma cells.
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/3054878-11892816,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3054878-2416366,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3054878-2434505,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3054878-2444978,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3054878-2445690,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3054878-2445850,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3054878-2829354,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3054878-2866182,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3054878-2871942,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3054878-2941150,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3054878-2997328,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3054878-3002607,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3054878-3023045,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3054878-3093092,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3054878-3125790,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3054878-3305075,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3054878-3316040,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3054878-3316421,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3054878-3491322,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3054878-3493322,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3054878-3501121,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3054878-3538015,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3054878-3726549,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3054878-3883191,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3054878-6159547,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3054878-6164058,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3054878-6376119
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0027-8424
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
85
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
8037-41
|
pubmed:dateRevised |
2009-11-18
|
pubmed:meshHeading |
|
pubmed:year |
1988
|
pubmed:articleTitle |
Growth inhibition of human breast carcinoma and leukemia/lymphoma cell lines by recombinant interferon-beta 2.
|
pubmed:affiliation |
Department of Virology, Weizmann Institute of Science, Rehovot, Israel.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|